Upregulated programmed death ligand 1 expression in nivolumab‐induced lichen nitidus: A follow‐up report with an immunohistochemical analysis-Reference-Cited by-同舟云学术

Upregulated programmed death ligand 1 expression in nivolumab‐induced lichen nitidus: A follow‐up report with an immunohistochemical analysis

Published:2020-07-08 Issue:9 Volume:47 Page:
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Komatsu‐Fujii Takayoshi¹²^ORCID,Nakajima Saeko¹^ORCID,Iwata Masashi¹,Kataoka Tatsuki³^ORCID,Hirata Masahiro³,Nomura Takashi¹^ORCID,Kabashima Kenji¹⁴^ORCID

Affiliation:

1. Department of Dermatology Kyoto University Graduate School of Medicine Kyoto Japan

2. Department of Dermatology Tenri Hospital Tenri Japan

3. Department of Diagnostic Pathology Kyoto University Graduate School of Medicine Kyoto Japan

4. Agency for Science, Technology and Research (A*STAR) Singapore Immunology Network (SIgN) and Skin Research Institute of Singapore (SRIS) Singapore Singapore

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15480

Reference5 articles.

1. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

2. Generalized Lichen Nitidus Following Anti–PD-1 Antibody Treatment

3. Lichen nitidus

4. The Etiology of Lichen Planus

5. Diffuse hair loss following anti‐programmed cell death‐1 antibody treatment: a case report with immunohistochemical analysis;Komatsu‐Fujii T;Eur J Dermatol,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Mechanisms of Cutaneous Immune-Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitors;Current Oncology;2023-07-18

2. Skin Manifestation Induced by Immune Checkpoint Inhibitors;Clinical, Cosmetic and Investigational Dermatology;2022-05

3. Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/oteracil (TS-1®) after nivolumab discontinuation;European Journal of Dermatology;2021-02